Suven Pharmaceuticals informs about open offer

26 Dec 2022 Evaluate

Suven Pharmaceuticals has informed that, Kotak Mahindra Capital Company (‘Manager to the Open Offer’) has submitted to BSE a copy of Public Announcement for the attention of the public shareholders of Suven Pharmaceuticals (‘Target Company’) under Regulation 3(1) and Regulation 4 read with Regulations 13, 14 and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto.

The above information is a part of company’s filings submitted to BSE.




Cohance Lifesciences Share Price

384.20 -15.50 (-3.88%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×